GlassScriptPrepare for your visit
Crystal L Jones
Infectious Disease · Lebanon, IN · NPI 1356307003
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,987.11
in general payments reported to CMS, 2019-2025 · $1,117 in 2025
The $1,117 reported for 2025 was more than what 80% of Infectious Disease providers received nationally (typical 2025 total: $187).
Who reported paying
General payments only, top 6 by amount.
- Cumberland Pharmaceuticals, INC. $789.24
- Abbvie INC. $588.56
- Amgen INC. $509.21
- Ucb, INC. $382.85
- Gilead Sciences, INC. $376.36
- Organogenesis INC. $286.11
Drugs and devices associated with these payments
Kerecis Surgiclose Kerecis Omega3 Marigen Vibativ Ubrelvy Briviact Mavyret Hizentra Qulipta Tremfya Strensiq Ingrezza Enbrel
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Crystal Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/60829/crystal-l-jones